Moritz Pross, Ulrich F Wellner*, Kim C Honselmann, Carlo Jung, Steffen Deichmann, Tobias Keck and Dirk Bausch
University Clinic. Luebeck, Germany
- *Corresponding Author:
- Ulrich Wellner
University Clinic Luebeck
Ratzeburger allee 160, 23562
Luebeck, Germany
Tel +49451/500-2000
E-mail dr.ulrich.wellner@gmail.com
Received December 20th, 2014 – Accepted January 26th, 2015
We performed a literature review for neadjuvant therapy in pancreatic cancer. We divided the results into resectable disease and local advanced pancreatic cancer. Results Neoadjuvant therapy in pancreatic cancer is safe. But currently no standard guidelines exist in neoadjuvant approaches on pancreatic cancer. For local advanced pancreatic cancer the available data tends to show a positive effect on survival rates for neoadjuvant approaches.
